BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 19477198)

  • 1. Functional consequences of Kv1.3 ion channel rearrangement into the immunological synapse.
    Tóth A; Szilágyi O; Krasznai Z; Panyi G; Hajdú P
    Immunol Lett; 2009 Jun; 125(1):15-21. PubMed ID: 19477198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol modifies the gating of Kv1.3 in human T lymphocytes.
    Hajdú P; Varga Z; Pieri C; Panyi G; Gáspár R
    Pflugers Arch; 2003 Mar; 445(6):674-82. PubMed ID: 12632187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The glycosylation state of Kv1.2 potassium channels affects trafficking, gating, and simulated action potentials.
    Watanabe I; Zhu J; Sutachan JJ; Gottschalk A; Recio-Pinto E; Thornhill WB
    Brain Res; 2007 May; 1144():1-18. PubMed ID: 17324383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comment on "Functional consequences of Kv1.3 ion channel rearrangement into the immunological synapse".
    Bittner S; Wiendl H; Meuth SG
    Immunol Lett; 2009 Aug; 125(2):156-7. PubMed ID: 19595706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Kv1.1 channel glycosylation on C-type inactivation and simulated action potentials.
    Sutachan JJ; Watanabe I; Zhu J; Gottschalk A; Recio-Pinto E; Thornhill WB
    Brain Res; 2005 Oct; 1058(1-2):30-43. PubMed ID: 16153617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arachidonic acid potently inhibits both postsynaptic-type Kv4.2 and presynaptic-type Kv1.4 IA potassium channels.
    Angelova PR; Müller WS
    Eur J Neurosci; 2009 May; 29(10):1943-50. PubMed ID: 19453640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open form of syntaxin-1A is a more potent inhibitor than wild-type syntaxin-1A of Kv2.1 channels.
    Leung YM; Kang Y; Xia F; Sheu L; Gao X; Xie H; Tsushima RG; Gaisano HY
    Biochem J; 2005 Apr; 387(Pt 1):195-202. PubMed ID: 15518587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KCNE4 suppresses Kv1.3 currents by modulating trafficking, surface expression and channel gating.
    Solé L; Roura-Ferrer M; Pérez-Verdaguer M; Oliveras A; Calvo M; Fernández-Fernández JM; Felipe A
    J Cell Sci; 2009 Oct; 122(Pt 20):3738-48. PubMed ID: 19773357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMJ-53A accelerates slow inactivation gating of voltage-gated K+ channels in mouse neuroblastoma N2A cells.
    Chao CC; Shieh J; Kuo SC; Wu BT; Hour MJ; Leung YM
    Neuropharmacology; 2008 Jun; 54(7):1128-35. PubMed ID: 18406431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The modulatory effect of zinc ions on voltage-gated potassium currents in cultured rat hippocampal neurons is not related to Kv1.3 channels.
    Teisseyre A; Mercik K; Mozrzymas JW
    J Physiol Pharmacol; 2007 Dec; 58(4):699-715. PubMed ID: 18195482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective agent riluzole dramatically slows inactivation of Kv1.4 potassium channels by a voltage-dependent oxidative mechanism.
    Xu L; Enyeart JA; Enyeart JJ
    J Pharmacol Exp Ther; 2001 Oct; 299(1):227-37. PubMed ID: 11561084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamate levels and activity of the T cell voltage-gated potassium Kv1.3 channel in patients with systemic lupus erythematosus.
    Poulopoulou C; Papadopoulou-Daifoti Z; Hatzimanolis A; Fragiadaki K; Polissidis A; Anderzanova E; Davaki P; Katsiari CG; Sfikakis PP
    Arthritis Rheum; 2008 May; 58(5):1445-50. PubMed ID: 18438846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Answer to the "comment on functional consequences of Kv1.3 ion channel rearrangement into the immunological synapse" by Stefan Bittner et al. [Immunol. Lett. 125 (Aug 15 (2)) (2009) 156-157].
    Hajdú P; Szilágyi O; Tóth A; Krasznai Z; Pocsai K; Panyi G
    Immunol Lett; 2010 Mar; 129(1):47-9. PubMed ID: 20079762
    [No Abstract]   [Full Text] [Related]  

  • 14. Electrophysiologic characterization of a novel hERG channel activator.
    Su Z; Limberis J; Souers A; Kym P; Mikhail A; Houseman K; Diaz G; Liu X; Martin RL; Cox BF; Gintant GA
    Biochem Pharmacol; 2009 Apr; 77(8):1383-90. PubMed ID: 19426677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kv1 potassium channel C-terminus constant HRETE region: arginine substitution affects surface protein level and conductance level of subfamily members differentially.
    Zhu J; Gomez B; Watanabe I; Thornhill WB
    Mol Membr Biol; 2007; 24(3):194-205. PubMed ID: 17520476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galantamine blocks cloned Kv2.1, but not Kv1.5 potassium channels.
    Zhang HX; Zhang W; Jin HW; Wang XL
    Brain Res Mol Brain Res; 2004 Nov; 131(1-2):136-40. PubMed ID: 15530663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of membrane lipid metabolites on lymphocyte potassium channel activity.
    Teisseyre A; Michalak K; Kuliszkiewicz-Janus M
    Cell Mol Biol Lett; 2002; 7(4):1095-109. PubMed ID: 12511977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential modulation of Kv1 channel-mediated currents by co-expression of Kvbeta3 subunit in a mammalian cell-line.
    Bähring R; Vardanyan V; Pongs O
    Mol Membr Biol; 2004; 21(1):19-25. PubMed ID: 14668135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental switch of the expression of ion channels in human dendritic cells.
    Zsiros E; Kis-Toth K; Hajdu P; Gaspar R; Bielanska J; Felipe A; Rajnavolgyi E; Panyi G
    J Immunol; 2009 Oct; 183(7):4483-92. PubMed ID: 19748986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N type rapid inactivation in human Kv1.4 channels: functional role of a putative C-terminal helix.
    Sankaranarayanan K; Varshney A; Mathew MK
    Mol Membr Biol; 2005; 22(5):389-400. PubMed ID: 16308273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.